Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression

Surgery

Volumn 140, Issue 6, 2006, Pages 899-906

  Saltman, Benjamin ^a   Singh, Bhuvanesh ^b   Hedvat, Cyrus V ^b   Wreesmann, Volkert B ^c   Ghossein, Ronald ^b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ANAPLASTIC CARCINOMA; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE; CONTROLLED STUDY; FREQUENCY ANALYSIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA; TISSUE MICROARRAY;

APOPTOSIS; CARCINOMA; CARCINOMA, PAPILLARY; CELL CYCLE; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; KI-67 ANTIGEN; MICROARRAY ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33845565405     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.07.027     Document Type: Article

References (25)

1. Cancer Facts & Figures 2005 Graphs and Figures. www.cancer.org/docroot/MED/content/MED_1_1_Most-Requested_Graphs_and_Figures_2005.asp.
2. Hiltzik D., Carlson D.L., Tuttle R.M., Chuai S., Ishill N., Shaha A., et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 15 (2006) 1286-1295 106
3. Rosai J., Carcangiu M.L., and DeLellis R.A. Tumors of the thyroid gland. J Clin Oncol 19 (2001) 2616-2625 In: Atlas of tumor pathology. Washington: Armed Forces Institute of Pathology. 1992
4. Wreesmann V.B., Ghossein R.A., Patel S.G., Harris C.P., Schnaser E.A., Shaha A.R., et al. Genome-wide appraisal of thyroid cancer progression. Am J Pathol 161 (2002) 1549-1556
5. Stojadinovic A., Ghossein R.A., Hoos A., Nissan A., Marshall D., Dudas M., et al. Adrenocortical carcinoma: clinical, morphological, and molecular characterization. J Clin Oncol 20 (2002) 941-950
6. Soda G., Antonaci A., Bosco D., Nardoni S., and Melis M. Expression of bcl-2, c-erbB-2, p53 and p21 (waf1-cip1) protein in thyroid carcinomas. J Exp Clin Cancer Res 18 (1999) 363-367
7. Goto A., Sakamoto A., and Machinami R. An immunohistochemical analysis of cyclin D1, p53, and p21waf1/cip 1 proteins in tumors originating from the follicular epithelium of the gland. Pathol Res Pract 197 (2001) 217-222
8. Schmid K.W., Bankfalvi A., Mucke S., Ofner D., Riehemann K., Schroder S., et al. Possible Relation of p53 and mdm-2 oncoprotein expression in carcinoma: a molecular-pathological and immunohistochemical study on paraffin-embedded tissue. Endocr Pathol 7 (1996) 121-130
9. Ito Y., Kobayashi T., Takeda T., Komoike Y., Wakasugi E., Tamaki Y., et al. Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues. Br J Cancer 74 (1996) 1269-1274
10. Zedenius J., Larsson C., Wallin G., Backdahl M., Aspenblad U., Hoog A., et al. Alterations of p53 and expression of WAF1/p21 in human thyroid tumors. Thyroid 6 (1996) 1-9
11. Tallini G., Garcia-Rostan G., Herrero A., Zelterman D., Viale G., Bosari S., et al. Downregulation of p27KIP1 and Ki67/Mib 1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 23 (1999) 678-685
12. Ito T., Seyama T., Mizuno T., Tsuyama N., Hayashi T., Hayashi Y., et al. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 52 (1992) 1369-1371
13. Godballe C., Asschenfeldt P., Jorgensen K.E., Bastholt L., Clausen P.P., Hansen T.P., et al. Prognostic factors in papillary and follicular thyroid carcinomas: p53 expression is a significant indicator of prognosis. Laryngoscope 108 (1998) 243-249
14. Hoos A., Stojadinovic A., Singh B., Dudas M.E., Leung D.H., Shaha A.R., et al. Clinical significance of molecular expression profiles of Hurthle cell tumors of the thyroid gland analyzed via tissue microarrays. Am J Pathol 160 (2001) 175-183
15. Siironen P., Norling S., Louhimo J., Haapiainen R., and Haglund C. Immunohistochemical expression of Bcl-2, Ki-67, and p21 in patients with papillary thyroid cancer. Tumour Biol 26 (2005) 50-56
16. Hosal S.A., Apel R.L., Freeman J.L., Azadian A., Rosen I.B., LiVolsi V.A., et al. Immunohistochemical localization of p53 in human thyroid neoplasms: correlation with biological behavior. Endocr Pathol 8 (1997) 21-28
17. Dobashi Y., Sakamoto A., Sugimura H., Mernyei M., Mori M., Oyama T., et al. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 17 (1993) 375-381
18. Pollina L., Pacini F., Fontanini G., Vignati S., Bevilacqua G., Basolo F., et al. Bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas. Br J Cancer 73 (1996) 139-143
19. Horie S., Hiroyuki M., Kanenori E., Tsuyoshi U., Takashima K., and Terada T. Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: correlations with clinicopathologic features. Pathology International 51 (2001) 11-15
20. Polsky D., Melzer K., Hazan C., Panageas K.S., Busam K., Drobnjak M., et al. MDM2 protein overexpression and prognosis in primary malignant melanoma. J Natl Cancer Inst 94 (2002) 1803-1806
21. Buglioni S., D'Agnano I., Cosimelli M., Vasselli S., D'Angelo C., Tedesco M., et al. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and Bcl-2. Int J Cancer 84 (1999) 545-552
22. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27 (Kip-1)-deficient mice. Cell 85 (1996) 733-744
23. Pickett C.A., Agoff S.N., Widman R.J., and Bronner M.P. Altered expression of cyclins and cell cycle inhibitors in papillary thyroid cancer: prognostic implications. Thyroid 15 (2005) 461-473
24. Wang S., Lloyd R.V., Hutzler M.J., Safran M.S., Patwardhan N.A., and Khan A. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol 13 (2000) 882-887
25. Zirbes T.K., Baldus S.E., Moeing S.P., Nolden S., Kunze D., Shafizadeh S.T., et al. Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int J Cancer 89 (2000) 14-18